BioFocus sells obesity drug rights

Drug discovery company BioFocus said today it had sold the rights to research into drugs that could treat obesity.

Saffron Walden, Essex-based BioFocus, which works in partnership with pharmaceutical and biotechnology companies, sold the rights to Swedish company Biovitrum to work on the anti-obesity research.